VEGFC and gastric carcinoma: In gastric carcinoma, elevated COX-2 expression was correlated with higher levels of vascular endothelial growth factor (VEGF)-C and lymphatic spread, highlighting COX-2’s key role in lymphatic metastasis and the VEGF-C lymphangiogenic pathway (31).